Efficacy and safety of sclerotherapy for digital mucous cysts

Jae Yong Sung, MiRyung Roh

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Digital mucous cysts (DMCs) are common tumor of the adjacent distal interphalangeal joint that causes leakage of mucinous material from the joint. There are various treatment modalities for DMCs, among which sclerotherapy has been reported as an effective alternative treatment. Objectives: To evaluate the safety and efficacy of sclerotherapy for DMC. Patients and methods: We retrospectively reviewed 12 patients with DMC treated with sclerotherapy. 0.5% Sodium tetradecyl sulfate 0.2-0.3cc was injected into the pseudocystic lesions after the complete evacuation of mucinous material. Results: Eleven of 12 lesions regressed successfully, including four lesions that resolved after a single treatment. The mean number of treatments was 2.4. The mean follow-up period was 18.3 months after the last treatment. There was one case of recurrence after the last treatment. Complications such as mild edema, inflammation and pain were noted in three patients, which resolved within few days. Conclusions: According to the results of the present study, sclerotherapy is a feasible alternative treatment modality for DMCs. Treatment was well tolerated with few side effects, and resulted in high cure rate. Due to its less invasive nature, high accessibility and favorable outcomes, sclerotherapy should be considered a satisfactory option for the treatment of DMC.

Original languageEnglish
Pages (from-to)415-418
Number of pages4
JournalJournal of Dermatological Treatment
Volume25
Issue number5
DOIs
Publication statusPublished - 2014 Oct 1

Fingerprint

Sclerotherapy
Cysts
Safety
Therapeutics
Sodium Tetradecyl Sulfate
Joints
Edema
Inflammation
Recurrence
Pain

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

@article{4f8bf647b9e6475fbb823aba6a850f7a,
title = "Efficacy and safety of sclerotherapy for digital mucous cysts",
abstract = "Background: Digital mucous cysts (DMCs) are common tumor of the adjacent distal interphalangeal joint that causes leakage of mucinous material from the joint. There are various treatment modalities for DMCs, among which sclerotherapy has been reported as an effective alternative treatment. Objectives: To evaluate the safety and efficacy of sclerotherapy for DMC. Patients and methods: We retrospectively reviewed 12 patients with DMC treated with sclerotherapy. 0.5{\%} Sodium tetradecyl sulfate 0.2-0.3cc was injected into the pseudocystic lesions after the complete evacuation of mucinous material. Results: Eleven of 12 lesions regressed successfully, including four lesions that resolved after a single treatment. The mean number of treatments was 2.4. The mean follow-up period was 18.3 months after the last treatment. There was one case of recurrence after the last treatment. Complications such as mild edema, inflammation and pain were noted in three patients, which resolved within few days. Conclusions: According to the results of the present study, sclerotherapy is a feasible alternative treatment modality for DMCs. Treatment was well tolerated with few side effects, and resulted in high cure rate. Due to its less invasive nature, high accessibility and favorable outcomes, sclerotherapy should be considered a satisfactory option for the treatment of DMC.",
author = "Sung, {Jae Yong} and MiRyung Roh",
year = "2014",
month = "10",
day = "1",
doi = "10.3109/09546634.2012.699180",
language = "English",
volume = "25",
pages = "415--418",
journal = "Journal of Dermatological Treatment",
issn = "0954-6634",
publisher = "Informa Healthcare",
number = "5",

}

Efficacy and safety of sclerotherapy for digital mucous cysts. / Sung, Jae Yong; Roh, MiRyung.

In: Journal of Dermatological Treatment, Vol. 25, No. 5, 01.10.2014, p. 415-418.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Efficacy and safety of sclerotherapy for digital mucous cysts

AU - Sung, Jae Yong

AU - Roh, MiRyung

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Background: Digital mucous cysts (DMCs) are common tumor of the adjacent distal interphalangeal joint that causes leakage of mucinous material from the joint. There are various treatment modalities for DMCs, among which sclerotherapy has been reported as an effective alternative treatment. Objectives: To evaluate the safety and efficacy of sclerotherapy for DMC. Patients and methods: We retrospectively reviewed 12 patients with DMC treated with sclerotherapy. 0.5% Sodium tetradecyl sulfate 0.2-0.3cc was injected into the pseudocystic lesions after the complete evacuation of mucinous material. Results: Eleven of 12 lesions regressed successfully, including four lesions that resolved after a single treatment. The mean number of treatments was 2.4. The mean follow-up period was 18.3 months after the last treatment. There was one case of recurrence after the last treatment. Complications such as mild edema, inflammation and pain were noted in three patients, which resolved within few days. Conclusions: According to the results of the present study, sclerotherapy is a feasible alternative treatment modality for DMCs. Treatment was well tolerated with few side effects, and resulted in high cure rate. Due to its less invasive nature, high accessibility and favorable outcomes, sclerotherapy should be considered a satisfactory option for the treatment of DMC.

AB - Background: Digital mucous cysts (DMCs) are common tumor of the adjacent distal interphalangeal joint that causes leakage of mucinous material from the joint. There are various treatment modalities for DMCs, among which sclerotherapy has been reported as an effective alternative treatment. Objectives: To evaluate the safety and efficacy of sclerotherapy for DMC. Patients and methods: We retrospectively reviewed 12 patients with DMC treated with sclerotherapy. 0.5% Sodium tetradecyl sulfate 0.2-0.3cc was injected into the pseudocystic lesions after the complete evacuation of mucinous material. Results: Eleven of 12 lesions regressed successfully, including four lesions that resolved after a single treatment. The mean number of treatments was 2.4. The mean follow-up period was 18.3 months after the last treatment. There was one case of recurrence after the last treatment. Complications such as mild edema, inflammation and pain were noted in three patients, which resolved within few days. Conclusions: According to the results of the present study, sclerotherapy is a feasible alternative treatment modality for DMCs. Treatment was well tolerated with few side effects, and resulted in high cure rate. Due to its less invasive nature, high accessibility and favorable outcomes, sclerotherapy should be considered a satisfactory option for the treatment of DMC.

UR - http://www.scopus.com/inward/record.url?scp=84890361571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890361571&partnerID=8YFLogxK

U2 - 10.3109/09546634.2012.699180

DO - 10.3109/09546634.2012.699180

M3 - Article

C2 - 22646527

AN - SCOPUS:84890361571

VL - 25

SP - 415

EP - 418

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

IS - 5

ER -